Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity.
Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity. Cancer Res. 2018 12 01; 78(23):6655-6665.
View in:
PubMed
subject areas
Animals
Animals
Antineoplastic Agents
Antineoplastic Agents
B7-H1 Antigen
B7-H1 Antigen
Cell Line, Tumor
Cell Line, Tumor
Cytotoxicity, Immunologic
Cytotoxicity, Immunologic
Gene Expression Profiling
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Gene Expression Regulation, Neoplastic
Humans
Humans
Immunity
Immunity
Immunologic Factors
Immunologic Factors
Immunomodulation
Immunomodulation
Melanoma, Experimental
Melanoma, Experimental
Mice
Mice
Neoplasms
Neoplasms
Thalidomide
Thalidomide
T-Lymphocyte Subsets
T-Lymphocyte Subsets
authors with profiles
Barish H Edil